select a format

Single User License
USD 250 INR 16073
Site License
USD 500 INR 32145
Corporate User License
USD 750 INR 48218

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


LEO Pharma AS-Pharmaceuticals & Healthcare-Deals and Alliances Profile

LEO Pharma AS-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH30947D
  • |
  • Pages: 40
  • |
  • July 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

LEO Pharma A/S (LEO Pharma) is a research-based pharmaceutical company. It undertakes the discovery, development, manufacture and commercialization of pharmaceuticals in the therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, eczema, skin infections, actinic keratosis and non-melanoma skin cancer, besides thrombosis. It also manufactures and markets products for the treatment of diseases in the areas of cardiovascular, bacterial infections, coagulation, osteoporosis and renal care. LEO Pharma markets its products worldwide and has presence in countries across Europe, the Middle East, Africa, Asia, North America, Central America, South America and Oceania. It is a wholly-owned subsidiary of The LEO Foundation. LEO Pharma is headquartered in Ballerup, Denmark.

LEO Pharma AS-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

LEO Pharma A/S, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

LEO Pharma A/S, Medical Devices Deals, 2011 to YTD 2017 10

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deal Details 13

Asset Purchase 13

LEO Pharma Acquires Global Dermatology Portfolio of Astellas Pharma for USD724 Million 13

Partnerships 14

Leo Pharma Enters into Licensing Agreement with Klox Technologies 14

Klox Technologies and LEO Pharma to Form Joint Venture 15

MorphoSys Enters into Agreement with LEO Pharma 15

LEO Pharma Enters into Agreement with Washington University School of Medicine 16

Leo Pharma Enters into Distribution Agreement with NeoPharm 17

arGEN-X Enters into Co-Development Agreement with Leo Pharma 18

Fidelta Enters into Drug Discovery Agreement with LEO Pharma 19

Leo Pharma Enters into Distribution and Co-Promotion Agreement with Kyowa Hakko Kirin 19

LEO Pharma And University of Queensland Enter Into Research Agreement For Skin Cancer 20

LEO Pharma Enters Into Research Agreement With 4SC For Inflammatory Skin Diseases 21

LEO Pharma To Enter Into Joint Venture With Charite To Form I2DEAL 22

LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 23

Licensing Agreements 24

LEO Pharma Enters into Licensing Agreement with AstraZeneca for Tralokinumab 24

LEO Pharma Enters into Licensing Agreement with AstraZeneca for Brodalumab 25

Leo Pharma Enters into Licensing Agreement with Japan Tobacco for JTE-052 26

LEO Pharma Enters Into Licensing Agreement With Virobay For Psoriasis Drug 27

Equity Offering 28

LEO Pharma Invests in Novopyxis 28

Asset Transactions 29

Amdipharm Mercury Completes Acquisition Of Fucithalmic, Ophthalmic Medicine, From LEO Pharma 29

LEO Pharma A/S-Key Competitors 30

Key Employees 31

Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 34

Financial Announcements 34

Apr 03, 2017: LEO Pharma 2016 result surpassed expectations 34

Apr 05, 2016: A satisfactory year with significant investments 36

Corporate Communications 37

Jun 23, 2017: LEO Pharma Appoints Chris Posner to Lead US Business 37

Jun 24, 2016: LEO Pharma strengthens Board of Directors 38

Product News 39

Feb 01, 2016: argenx receives milestone payment in LEO Pharma collaboration 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

LEO Pharma A/S, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

LEO Pharma A/S, Pharmaceuticals & Healthcare, Key Facts, 2016 1

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

LEO Pharma A/S, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

LEO Pharma A/S, Deals By Therapy Area, 2011 to YTD 2017 9

LEO Pharma A/S, Medical Devices Deals, 2011 to YTD 2017 10

LEO Pharma A/S, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

LEO Pharma Acquires Global Dermatology Portfolio of Astellas Pharma for USD724 Million 13

Leo Pharma Enters into Licensing Agreement with Klox Technologies 14

Klox Technologies and LEO Pharma to Form Joint Venture 15

MorphoSys Enters into Agreement with LEO Pharma 15

LEO Pharma Enters into Agreement with Washington University School of Medicine 16

Leo Pharma Enters into Distribution Agreement with NeoPharm 17

arGEN-X Enters into Co-Development Agreement with Leo Pharma 18

Fidelta Enters into Drug Discovery Agreement with LEO Pharma 19

Leo Pharma Enters into Distribution and Co-Promotion Agreement with Kyowa Hakko Kirin 19

LEO Pharma And University of Queensland Enter Into Research Agreement For Skin Cancer 20

LEO Pharma Enters Into Research Agreement With 4SC For Inflammatory Skin Diseases 21

LEO Pharma To Enter Into Joint Venture With Charite To Form I2DEAL 22

LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 23

LEO Pharma Enters into Licensing Agreement with AstraZeneca for Tralokinumab 24

LEO Pharma Enters into Licensing Agreement with AstraZeneca for Brodalumab 25

Leo Pharma Enters into Licensing Agreement with Japan Tobacco for JTE-052 26

LEO Pharma Enters Into Licensing Agreement With Virobay For Psoriasis Drug 27

LEO Pharma Invests in Novopyxis 28

Amdipharm Mercury Completes Acquisition Of Fucithalmic, Ophthalmic Medicine, From LEO Pharma 29

LEO Pharma A/S, Key Competitors 30

LEO Pharma A/S, Key Employees 31

LEO Pharma A/S, Subsidiaries 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

LEO Pharma AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com